McAdam LLC’s Fulgent Genetics FLGT Stock Holding History

McAdam LLC’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-250	Closed	-$1K	–	228
2018 Q3	$1K	Hold	250	–	–	﹤0.01%	574
2018 Q2	$1K	Hold	250	–	–	﹤0.01%	548
2018 Q1	$1K	Buy	+250	New	+$1.1K	﹤0.01%	631

Other funds holding FLGT

OWIM

Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return

Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

McAdam LLC's FLGT Position: Q4 2018 in Review

McAdam LLC sold out of Fulgent Genetics (FLGT) in Q4 2018, closing a stake of 250 shares — an estimated $1K sold.

McAdam LLC first reported a position in FLGT in Q1 2018 and held it in 3 quarters. The position peaked at $1K in Q3 2018. 15 funds tracked by Wall St. Rank hold FLGT as of Q4 2018.

McAdam LLC reported no remaining Fulgent Genetics position as of Q4 2018 after selling out during the quarter.
McAdam LLC sold 250 Fulgent Genetics shares in Q4 2018, an estimated $1K.
McAdam LLC first reported a position in Fulgent Genetics in Q1 2018 and held it in 3 quarters.
McAdam LLC's Fulgent Genetics position peaked at $1K in Q3 2018.
15 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2018.

Based on McAdam LLC's 13F filing for Q4 2018, filed 30 Jan 2019.